In this interview recorded at the MAPS 2023 Annual Meeting in Nashville, MAPS speaks with Robin Winter-Sperry and Robert Kersting, PharmD, Global Head, Scientific Alliances, Novartis, about the need for multi-stakeholder partnerships.
https://medicalaffairs.org/wp-content/uploads/2023/05/External-Partnerships-Featured.png321845Medical Affairshttps://medicalaffairs.org/wp-content/uploads/2022/11/MAPS-Logo-R-NoTagLine.pngMedical Affairs2023-05-03 14:02:202023-11-10 14:22:19Robert Kersting & Robin Winter-Sperry: The Power of External Partnerships
In this interview recorded at the MAPS 2023 Annual Meeting in Nashville, MAPS speaks with Jim Wilkinson, PhD, Vice President, Global & US Medical Affairs, Amgen, about how to develop Medical Affairs talent into tomorrow’s leaders.
https://medicalaffairs.org/wp-content/uploads/2023/04/Jim-Wilkinson-Featured.png321845Medical Affairshttps://medicalaffairs.org/wp-content/uploads/2022/11/MAPS-Logo-R-NoTagLine.pngMedical Affairs2023-04-28 09:41:142023-11-10 14:22:50Jim Wilkinson, PhD: Developing Staff to be the Leaders of Tomorrow
Streamlining the diagnostic odyssey requires educating medical professionals to recognize “rare encounters” and engage these patients with precision and compassion.
https://medicalaffairs.org/wp-content/uploads/2023/03/Rare-Encounters-Featured.png321845Medical Affairshttps://medicalaffairs.org/wp-content/uploads/2022/11/MAPS-Logo-R-NoTagLine.pngMedical Affairs2023-03-02 10:43:532023-03-02 10:47:49Educating Medical Professionals for that “Rare Encounter”
https://medicalaffairs.org/wp-content/uploads/2023/01/ChatGPT-Featured-2.png321845Medical Affairshttps://medicalaffairs.org/wp-content/uploads/2022/11/MAPS-Logo-R-NoTagLine.pngMedical Affairs2023-01-26 09:38:432023-11-10 14:38:07ChatGPT is Poised to Disrupt Medical Affairs
From space biology to patient voice to best practices for onboarding, here are highlights of the APPA/MAPS Joint Medical Affairs Summit in Sydney, Australia.
https://medicalaffairs.org/wp-content/uploads/2022/12/Screenshot-2022-12-15-at-9.10.18-AM-1.png9942182Travis Hegehttps://medicalaffairs.org/wp-content/uploads/2022/11/MAPS-Logo-R-NoTagLine.pngTravis Hege2022-12-15 09:26:552022-12-15 09:28:14Highlights from the APPA/MAPS Joint Medical Affairs Summit 2022
At the MAPS 2022 Global Annual Meeting in New Orleans, we sat down with Medical Affairs leaders in attendance to discuss a range of issues important to the function. Now as we prepare for the MAPS 2023 Global Annual Meeting in Nashville, March 26-29 (early bird registration open until December 31!), join us in looking back at these important opinions. Have a topic you’d like covered at the 2023 meeting? Email MAPS Communications/Marketing Director, Garth Sundem, with your suggestions!
https://medicalaffairs.org/wp-content/uploads/2022/04/Monica-de-Abadal-Medical-Affairs-Table-Talk-Episode-07-WordPress-Image-1.png321845Medical Affairshttps://medicalaffairs.org/wp-content/uploads/2022/11/MAPS-Logo-R-NoTagLine.pngMedical Affairs2022-12-07 14:59:172023-04-12 12:46:23Medical Affairs Leadership Interviews from the MAPS 2022 Global Annual Meeting
https://medicalaffairs.org/wp-content/uploads/2022/08/Broadening-Role-Featured.png321845Medical Affairshttps://medicalaffairs.org/wp-content/uploads/2022/11/MAPS-Logo-R-NoTagLine.pngMedical Affairs2022-08-31 12:32:002023-11-13 08:12:19The Broadening Role of Medical Affairs
MAPS speaks with Annemarie Clegg, CMO, OPEN Health, about the evolving role of Medical Affairs in providing context for payers, regulators and policy makers whose decisions can dramatically affect which patients can access industry innovations.
https://medicalaffairs.org/wp-content/uploads/2022/07/Annemarie-Open-Health-TLI-Featured.png321845Medical Affairshttps://medicalaffairs.org/wp-content/uploads/2022/11/MAPS-Logo-R-NoTagLine.pngMedical Affairs2022-07-12 17:31:322022-07-12 17:31:32The Role of Medical Affairs in Market Access: A Conversation with Annemarie Clegg, CMO, OPEN Health
At the MAPS 2022 Global Annual Meeting, we sat down with Riad Dirani, Vice President of Global Health Economics and Outcomes Research at Teva Pharmaceuticals, and Omar Dabbous, Vice President of Global Health Economics and Outcomes Research and Real World Evidence at AveXis to chat about the structure and activities of HEOR within Medical Affairs.
Access Options
https://medicalaffairs.org/wp-content/uploads/2022/06/Riad-and-Omar-Medical-Affairs-Table-Talk-Episode-12-WordPress-Image.png321845MGluckle@MedicalAffairs.orghttps://medicalaffairs.org/wp-content/uploads/2022/11/MAPS-Logo-R-NoTagLine.pngMGluckle@MedicalAffairs.org2022-06-07 00:05:022024-04-24 16:01:48The Emerging Importance of HEOR in Medical Affairs
MAPS members represent the full range of Medical Affairs professionals, from those leading or working in large organizations, to those tasked with starting a Medical Affairs function at startup or emerging organizations. Here, MAPS speaks with Lobna Salem, Regional Chief Medical officer Developed Markets& Japan Australia and New Zealand at Viatris, about the process of building Medical Affairs from scratch.
Access Options
https://medicalaffairs.org/wp-content/uploads/2022/05/Lobna-Salem-Featured.png321845gsundem@medicalaffairs.orghttps://medicalaffairs.org/wp-content/uploads/2022/11/MAPS-Logo-R-NoTagLine.pnggsundem@medicalaffairs.org2022-05-12 20:30:012024-04-25 12:33:24Building Medical Affairs from Scratch
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.